Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 3990-3994

  Baker, Rocky L ^a   Delong, Thomas ^a   Barbour, Gene ^a   Bradley, Brenda ^a   Nakayama, Maki ^a   Haskins, Kathryn ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; PEPTIDE KS20; TETRAMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETOGENESIS; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE CLONE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN BINDING; TH1 CELL;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; HISTOCOMPATIBILITY ANTIGENS CLASS II; ISLET AMYLOID POLYPEPTIDE; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; PANCREAS; PREDIABETIC STATE; SPLEEN;

EID: 84885458132     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301480     Document Type: Article

References (23)

1. Cantor, J., and K. Haskins. 2005. Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-Alpha. J. Immunol. 175: 7738-7745.
2. Haskins, K. 2005. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv. Immunol. 87: 123-162.
3. Stadinski, B. D., T. Delong, N. Reisdorph, R. Reisdorph, R. L. Powell, M. Armstrong, J. D. Piganelli, G. Barbour, B. Bradley, F. Crawford, et al. 2010. Chromogranin A is an autoantigen in type 1 diabetes. Nat. Immunol. 11: 225-231.
4. Delong, T., R. L. Baker, N. Reisdorph, R. Reisdorph, R. L. Powell, M. Armstrong, G. Barbour, B. Bradley, and K. Haskins. 2011. Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells. Diabetes 60: 2325-2330.
5. Nepom, G. T. 2012. MHC class II tetramers. J. Immunol. 188: 2477-2482.
6. DiLorenzo, T. P. 2011. Multiple antigens versus single major antigen in type 1 diabetes: arguing for multiple antigens. Diabetes Metab. Res. Rev. 27: 778-783.
7. Stratmann, T., N. Martin-Orozco, V. Mallet-Designe, L. Poirot, D. McGavern, G. Losyev, C. M. Dobbs, M. B. Oldstone, K. Yoshida, H. Kikutani, et al. 2003. Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. J. Clin. Invest. 112: 902-914.
8. Gebre-Medhin, S., H. Mulder, M. Pekny, G. Westermark, J. Törnell, P. Westermark, F. Sundler, B. Ahrén, and C. Betsholtz. 1998. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem. Biophys. Res. Commun. 250: 271-277.
9. Yoshida, K., T. Martin, K. Yamamoto, C. Dobbs, C. Münz, N. Kamikawaji, N. Nakano, H. G. Rammensee, T. Sasazuki, K. Haskins, and H. Kikutani. 2002. Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones. Int. Immunol. 14: 1439-1447.
10. Haskins, K., M. Portas, B. Bergman, K. Lafferty, and B. Bradley. 1989. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 86: 8000-8004.
11. Baker, R. L., T. Mallevaey, L. Gapin, and K. Haskins. 2012. T cells interact with T cells via CD40-CD154 to promote autoimmunity in type 1 diabetes. Eur. J. Immunol. 42: 672-680.
12. Bergman, B., J. L. McManaman, and K. Haskins. 2000. Biochemical characterization of a beta cell membrane fraction antigenic for autoreactive T cell clones. J. Autoimmun. 14: 343-351.
13. Liu, C. P., K. Jiang, C. H. Wu, W. H. Lee, and W. J. Lin. 2000. Detection of glutamic acid decarboxylase-Activated T cells with I-Ag7 tetramers. Proc. Natl. Acad. Sci. USA 97: 14596-14601.
14. Crawford, F., B. Stadinski, N. Jin, A. Michels, M. Nakayama, P. Pratt, P. Marrack, G. Eisenbarth, and J. W. Kappler. 2011. Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse. Proc. Natl. Acad. Sci. USA 108: 16729-16734.
15. Latek, R. R., A. Suri, S. J. Petzold, C. A. Nelson, O. Kanagawa, E. R. Unanue, and D. H. Fremont. 2000. Structural basis of peptide binding and presentation by the type I diabetes-Associated MHC class II molecule of NOD mice. Immunity 12: 699-710.
16. Sabatino, J. J., Jr., J. Huang, C. Zhu, and B. D. Evavold. 2011. High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses. J. Exp. Med. 208: 81-90.
17. Corse, E., R. A. Gottschalk, and J. P. Allison. 2011. Strength of TCR-peptide/ MHC interactions and in vivo T cell responses. J. Immunol. 186: 5039-5045.
18. Gottschalk, R. A., E. Corse, and J. P. Allison. 2010. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207: 1701-1711.
19. Rogers, P. R., and M. Croft. 1999. Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance. J. Immunol. 163: 1205-1213.
20. Wenzlau, J. M., K. Juhl, L. Yu, O. Moua, S. A. Sarkar, P. Gottlieb, M. Rewers, G. S. Eisenbarth, J. Jensen, H. W. Davidson, and J. C. Hutton. 2007. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. USA 104: 17040-17045.
21. Delong, T., R. L. Baker, J. He, G. Barbour, B. Bradley, and K. Haskins. 2012. Diabetogenic T-cell clones recognize an altered peptide of chromogranin A. Diabetes 61: 3239-3246.
22. Gorus, F. K., J. C. Sodoyez, D. G. Pipeleers, B. Keymeulen, A. Foriers, and C. F. Van Schravendijk. 1992. Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry. Diabetologia 35: 1080-1086.
23. Panagiotopoulos, C., H. Qin, R. Tan, and C. B. Verchere. 2003. Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes. Diabetes 52: 2647-2651.